Jump to navigation
The latest clinical and political news for Australian Neurologists
Study highlights diverse adverse events.
Lancet study suggests a third of cases preventable.
Endovascular thrombectomy enters the guidelines for the first time.
Haemorrhagic stroke risk higher for methamphetamine users under 45
Combinations of paracetamol and ibuprofen are better than weak opioid
The results contribute to a growing body of evidence linking midlife vascular health to dementia.
It's up to the individual pharmacy.
Once thought of as a laugh, concussion is now being taken seriously by the NRL.
Hiccups lasting 48 hours were a presenting sign
Low dose risperidone is being widely used for dementia
'These medicines are not as easy to prescribe as we think'
There is scope for streamlining
A study suggests it's an unreliable indicator of driving skills.
Neurosurgeons have turned to Hollywood to help hone their hand–eye co-ordination.
An Australian study looks at older men
Much depends on the covariates used, a study shows.
Reported effects are variable and small, and many studies are of poor quality.
Mildly impaired patients are no more likely to fail driving tests.
We speak with neurologist and ANZAN president Professor Matthew Kiernan.
Lipid profiles appear to affect the disease course
Australian Doctor Group (ADG) is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.
Ensure you never miss a big story by signing up for our daily e-newsletter.